Wednesday, June 13, 2007 4:35:57 PM
Dutch researchers have overcome the traditional incompatibility of Raman microscopy with fluorescence microscopy by exploiting the optical properties of semiconductor fluorescent quantum dots (QDs). They have now used their hybrid Raman fluorescence spectral imaging approach in single-cell microscopy applications.
Biophysical engineers Henk-Jan van Manen and Cees Otto of the University of Twente, The Netherlands, have used fluorescent nanoparticles to broaden the scope of single-cell microscopy by combining it with intracellular chemical analysis based on Raman.
According to the researchers, the need for fluorescent nanoparticles, or quantum dots, arises because common fluorescent labels overshadow the intrinsically weak Raman signals from DNA, proteins and lipids in cells. To side-step this problem, the team used fluorescent quantum dots that emit light in a wavelength region that is well-separated from Raman signals.
The group at the University of Twente has pioneered the use of Raman spectroscopy in investigating the chemical make-up of single cells. Van Manen and Otto have now demonstrated successfully the hybrid technique by illuminating white blood cells under UV at 413 nm, and observing the Raman signal from an enzyme critical to the innate immune response. This allowed them to detect and visualize the enzyme across the cell. In a second proof of principle experiment, the team used 647 nm light to investigate cellular proteins and lipids.
Van Manen and Otto say that the fluorescence Raman microscopy combination provides exciting new possibilities because the nanoparticles coated with antibodies raised against cancer biomarkers could be used to guide Raman microscopy to certain areas in tissues and allow the spread of cancer in a patient to be detected with molecular precision.
"We have exploited the optical properties of nanosized quantum dots to develop two new strategies for combining confocal Raman microscopy with confocal fluorescence microscopy on QD-labelled biological cells," conclude the researchers. The first approach uses resonant Raman microspectroscopy and imaging of enzymes, in this case flavocytochrome b558, and is, the team says, fully compatible with linear fluorescence microscopy of intracellular QDs.
The second method involves continuous-wave two-photon-excited fluorescence of the QDs in white blood cells and does not interfere with non-resonant Raman signals produced by proteins or lipids in the cells. "As these hybrid Raman fluorescence strategies should be applicable to any cell type that is amenable to labelling with QDs," the researchers add, "we envision that hybrid Raman fluorescence microscopy will offer new prospects for integrating QD imaging on cells with spatially resolved, detailed intracellular chemical analysis by broadband Raman microspectroscopy."
Infrared and Raman vibrational spectroscopies reveal the palette of frescos found in the medieval monastery of Karaach Teke
Annali di Chimica, 2007, 97, 491-503
T. Zorba, K.S. Andrikopoulos, K.M. Paraskevopoulos, E. Pavlidou, K. Popkonstantinov, R. Kostova, V. Platnyov, Sister Daniilia
//////////////////////////////////////////////////////////////
Abstract: Vibrational spectroscopy is applied on samples obtained from the excavation area of the medieval Monastery (10th century) of Karaach-Teke in Bulgaria. The results of the corresponding study, reveal the type of materials used for the creation of the wall-paintings and give evidence of Byzantine influence, a fact that further supports the well known impact of Byzantium on the technology and thematic-aesthetic features of iconography in Bulgaria during this era. In addition, the complementarity of FTIR and µ-Raman spectroscopies in the identification of pigments is indicated.
NOTE Vibrational=resonant. (I think) Alla this may be a bit beyond my pay grade...but may be of interest,,
Ole Crowe
Recent IVAC News
- Intevac Announces First Quarter 2024 Financial Results • Business Wire • 04/25/2024 11:00:00 AM
- Intevac Announces Earlier Release Date of Thursday, April 25th for First Quarter 2024 Results • Business Wire • 04/22/2024 01:00:00 PM
- Intevac to Announce First Quarter 2024 Results on April 29th • Business Wire • 04/15/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 09:02:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:34:36 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:07:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:06:07 PM
- Intevac Announces Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/05/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 03:35:07 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 10:26:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 03:37:25 PM
- Intevac to Announce Fourth Quarter and Fiscal Year 2023 Results on February 5th • Business Wire • 01/16/2024 02:00:00 PM
- Intevac Announces Successful Qualification of TRIO™ System • Business Wire • 01/02/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:01:32 PM
- Intevac Announces Participation in 12th Annual NYC Summit • Business Wire • 11/16/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:06:02 PM
- Intevac Announces Third Quarter 2023 Financial Results • Business Wire • 11/01/2023 08:05:00 PM
- Intevac to Announce Third Quarter 2023 Results on November 1st • Business Wire • 10/11/2023 08:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/22/2023 08:05:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 05:08:46 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 03:36:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2023 09:27:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/03/2023 08:32:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 08:06:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM